SHELL ASSET MANAGEMENT CO - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$557
-12.4%
21,804
-1.7%
0.02%
-8.0%
Q2 2023$636
-10.7%
22,181
-25.3%
0.02%
-16.7%
Q1 2023$712
+164.7%
29,698
+87.3%
0.03%
+150.0%
Q4 2022$269
-99.6%
15,855
+950.0%
0.01%
+500.0%
Q3 2020$65,000
-8.5%
1,5100.0%0.00%0.0%
Q2 2020$71,0001,5100.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders